Genotoxic impurities: strategies for identification and control
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Hoboken, N.J.
Wiley
©2010
|
Schlagworte: | |
Online-Zugang: | FRO01 UBG01 URL des Erstveröffentlichers |
Beschreibung: | Includes bibliographical references and index This book examines genotoxic impurities and their impact on the pharmaceutical industry. Specific sections examine this from both a toxicological and analytical perspective. Within these sections, the book defines appropriate strategies to both assess and ultimately control genotoxic impurities, thus aiding the reader to develop effective control measures. An opening section covers the development of guidelines and the threshold of toxicological concern (TTC) and is followed by a section on safety aspects, including safety tests in vivo and vitro, and data interpretation. T. |
Beschreibung: | 1 Online-Ressource (xii, 428 pages) |
ISBN: | 9780470929360 0470929367 9780470929377 0470929375 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043392700 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 160222s2010 |||| o||u| ||||||eng d | ||
020 | |a 9780470929360 |c electronic bk. |9 978-0-470-92936-0 | ||
020 | |a 0470929367 |c electronic bk. |9 0-470-92936-7 | ||
020 | |a 9780470929377 |c electronic bk. |9 978-0-470-92937-7 | ||
020 | |a 0470929375 |c electronic bk. |9 0-470-92937-5 | ||
024 | 7 | |a 10.1002/9780470929377 |2 doi | |
035 | |a (ZDB-35-WIC)ocn698591455 | ||
035 | |a (OCoLC)698591455 | ||
035 | |a (DE-599)BVBBV043392700 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-861 | ||
082 | 0 | |a 616/.042 |2 22 | |
245 | 1 | 0 | |a Genotoxic impurities |b strategies for identification and control |c edited by Andrew Teasdale |
264 | 1 | |a Hoboken, N.J. |b Wiley |c ©2010 | |
300 | |a 1 Online-Ressource (xii, 428 pages) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
500 | |a This book examines genotoxic impurities and their impact on the pharmaceutical industry. Specific sections examine this from both a toxicological and analytical perspective. Within these sections, the book defines appropriate strategies to both assess and ultimately control genotoxic impurities, thus aiding the reader to develop effective control measures. An opening section covers the development of guidelines and the threshold of toxicological concern (TTC) and is followed by a section on safety aspects, including safety tests in vivo and vitro, and data interpretation. T. | ||
650 | 4 | |a Mutagenicity Tests / methods | |
650 | 4 | |a Drug Toxicity / prevention & control | |
650 | 4 | |a Mutagens / adverse effects | |
650 | 4 | |a Mutagens / analysis | |
650 | 4 | |a Toxicogenetics / methods | |
650 | 7 | |a HEALTH & FITNESS / Diseases / Genetic |2 bisacsh | |
650 | 7 | |a MEDICAL / Genetics |2 bisacsh | |
650 | 7 | |a Drugs / Toxicology |2 fast | |
650 | 7 | |a Genetic toxicology |2 fast | |
650 | 4 | |a Medizin | |
650 | 4 | |a Genetic toxicology | |
650 | 4 | |a Drugs / Toxicology | |
650 | 0 | 7 | |a Gentoxikologie |0 (DE-588)4338045-1 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Gentoxikologie |0 (DE-588)4338045-1 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
700 | 1 | |a Teasdale, Andrew |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-470-49919-1 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-470-49919-2 |
856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9780470929377 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-35-WIC | ||
940 | 1 | |q UBG_PDA_WIC | |
999 | |a oai:aleph.bib-bvb.de:BVB01-028811284 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9780470929377 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9780470929377 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804175969413496832 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV043392700 |
collection | ZDB-35-WIC |
ctrlnum | (ZDB-35-WIC)ocn698591455 (OCoLC)698591455 (DE-599)BVBBV043392700 |
dewey-full | 616/.042 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616/.042 |
dewey-search | 616/.042 |
dewey-sort | 3616 242 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03072nmm a2200625zc 4500</leader><controlfield tag="001">BV043392700</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470929360</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-92936-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470929367</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-92936-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470929377</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-92937-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470929375</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-92937-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9780470929377</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn698591455</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)698591455</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043392700</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616/.042</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Genotoxic impurities</subfield><subfield code="b">strategies for identification and control</subfield><subfield code="c">edited by Andrew Teasdale</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, N.J.</subfield><subfield code="b">Wiley</subfield><subfield code="c">©2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xii, 428 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This book examines genotoxic impurities and their impact on the pharmaceutical industry. Specific sections examine this from both a toxicological and analytical perspective. Within these sections, the book defines appropriate strategies to both assess and ultimately control genotoxic impurities, thus aiding the reader to develop effective control measures. An opening section covers the development of guidelines and the threshold of toxicological concern (TTC) and is followed by a section on safety aspects, including safety tests in vivo and vitro, and data interpretation. T.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mutagenicity Tests / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Toxicity / prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mutagens / adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mutagens / analysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicogenetics / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Genetic</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Genetics</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Toxicology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genetic toxicology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Toxicology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gentoxikologie</subfield><subfield code="0">(DE-588)4338045-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Gentoxikologie</subfield><subfield code="0">(DE-588)4338045-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teasdale, Andrew</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-470-49919-1</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-470-49919-2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9780470929377</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028811284</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9780470929377</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9780470929377</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV043392700 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:24:44Z |
institution | BVB |
isbn | 9780470929360 0470929367 9780470929377 0470929375 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028811284 |
oclc_num | 698591455 |
open_access_boolean | |
owner | DE-861 |
owner_facet | DE-861 |
physical | 1 Online-Ressource (xii, 428 pages) |
psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | Wiley |
record_format | marc |
spelling | Genotoxic impurities strategies for identification and control edited by Andrew Teasdale Hoboken, N.J. Wiley ©2010 1 Online-Ressource (xii, 428 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index This book examines genotoxic impurities and their impact on the pharmaceutical industry. Specific sections examine this from both a toxicological and analytical perspective. Within these sections, the book defines appropriate strategies to both assess and ultimately control genotoxic impurities, thus aiding the reader to develop effective control measures. An opening section covers the development of guidelines and the threshold of toxicological concern (TTC) and is followed by a section on safety aspects, including safety tests in vivo and vitro, and data interpretation. T. Mutagenicity Tests / methods Drug Toxicity / prevention & control Mutagens / adverse effects Mutagens / analysis Toxicogenetics / methods HEALTH & FITNESS / Diseases / Genetic bisacsh MEDICAL / Genetics bisacsh Drugs / Toxicology fast Genetic toxicology fast Medizin Genetic toxicology Drugs / Toxicology Gentoxikologie (DE-588)4338045-1 gnd rswk-swf Gentoxikologie (DE-588)4338045-1 s 1\p DE-604 Teasdale, Andrew Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 978-0-470-49919-1 Erscheint auch als Druck-Ausgabe, Hardcover 0-470-49919-2 https://onlinelibrary.wiley.com/doi/book/10.1002/9780470929377 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Genotoxic impurities strategies for identification and control Mutagenicity Tests / methods Drug Toxicity / prevention & control Mutagens / adverse effects Mutagens / analysis Toxicogenetics / methods HEALTH & FITNESS / Diseases / Genetic bisacsh MEDICAL / Genetics bisacsh Drugs / Toxicology fast Genetic toxicology fast Medizin Genetic toxicology Drugs / Toxicology Gentoxikologie (DE-588)4338045-1 gnd |
subject_GND | (DE-588)4338045-1 |
title | Genotoxic impurities strategies for identification and control |
title_auth | Genotoxic impurities strategies for identification and control |
title_exact_search | Genotoxic impurities strategies for identification and control |
title_full | Genotoxic impurities strategies for identification and control edited by Andrew Teasdale |
title_fullStr | Genotoxic impurities strategies for identification and control edited by Andrew Teasdale |
title_full_unstemmed | Genotoxic impurities strategies for identification and control edited by Andrew Teasdale |
title_short | Genotoxic impurities |
title_sort | genotoxic impurities strategies for identification and control |
title_sub | strategies for identification and control |
topic | Mutagenicity Tests / methods Drug Toxicity / prevention & control Mutagens / adverse effects Mutagens / analysis Toxicogenetics / methods HEALTH & FITNESS / Diseases / Genetic bisacsh MEDICAL / Genetics bisacsh Drugs / Toxicology fast Genetic toxicology fast Medizin Genetic toxicology Drugs / Toxicology Gentoxikologie (DE-588)4338045-1 gnd |
topic_facet | Mutagenicity Tests / methods Drug Toxicity / prevention & control Mutagens / adverse effects Mutagens / analysis Toxicogenetics / methods HEALTH & FITNESS / Diseases / Genetic MEDICAL / Genetics Drugs / Toxicology Genetic toxicology Medizin Gentoxikologie |
url | https://onlinelibrary.wiley.com/doi/book/10.1002/9780470929377 |
work_keys_str_mv | AT teasdaleandrew genotoxicimpuritiesstrategiesforidentificationandcontrol |